Differences in airway remodeling between asthma and chronic obstructive pulmonary disease.
about
Hematopoietic and mesenchymal stem cells for the treatment of chronic respiratory diseases: role of plasticity and heterogeneityDynamics of airway response in lung microsections: a tool for studying airway-extra cellular matrix interactionsAirway Gland Structure and FunctionTumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype.Mouse models to unravel the role of inhaled pollutants on allergic sensitization and airway inflammationDoes Inhalation of Virgin Coconut Oil Accelerate Reversal of Airway Remodelling in an Allergic Model of Asthma?Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease.High mobility group box 1 induced human lung myofibroblasts differentiation and enhanced migration by activation of MMP-9.Asthma in the Elderly: Can We Distinguish It from COPD?Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy.Resveratrol has protective effects against airway remodeling and airway hyperreactivity in a murine model of allergic airways diseaseA Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids.State of the art. Apoptosis and cell homeostasis in chronic obstructive pulmonary disease.Cell death, remodeling, and repair in chronic obstructive pulmonary disease?Animal models of asthma.The Expression of NOX4 in Smooth Muscles of Small Airway Correlates with the Disease Severity of COPDMicroparticulate/Nanoparticulate Powders of a Novel Nrf2 Activator and an Aerosol Performance Enhancer for Pulmonary Delivery Targeting the Lung Nrf2/Keap-1 Pathway.Leukocyte elastase induces lung epithelial apoptosis via a PAR-1-, NF-kappaB-, and p53-dependent pathway.Cellular therapies for lung disease: a distant horizon.Can anti-IgE therapy prevent airway remodeling in allergic asthma?Angiogenesis and vascular remodeling in chronic airway diseases.The footprint of TGF-β in airway remodeling of the mustard lung.Asthma and COPD: Similarities and Differences in the Pathophysiology, Diagnosis and Therapy.Matrix Metalloproteinase-9 (279R/Q) Polymorphism is Associated with Clinical Severity and Airflow Limitation in Tunisian Patients with Chronic Obstructive Pulmonary Disease.Anti-TNFα therapy in inflammatory lung diseases.Model-based evaluation of pulmonary pharmacokinetics in asthmatic and COPD patients after oral olodaterol inhalation.CD4/CD8 ratio and cytokine levels of the BAL fluid in patients with bronchiectasis caused by sulfur mustard gas inhalation.Effects of n-3 PUFA on the CD4⁺ type 2 helper T-cell-mediated immune responses in Fat-1 mice.Cordyceps sinensis inhibits airway remodeling in rats with chronic obstructive pulmonary disease.Interstitial changes in asthma-COPD overlap syndrome.
P2860
Q21284513-4DC0FB32-B19D-47F7-B11F-625CB6189A8CQ26749716-B9229DC0-EA18-4F04-95F4-79FAD267F832Q28082284-7C2B6957-3B23-4B0B-8DC8-1FC1D0F9CF54Q30489186-2531BDD7-D0B5-41CB-B5B6-37F84C8CCFF9Q33702318-F618400E-30D5-4DB8-B973-5F581C7C0E79Q33808911-F5565C5B-B006-4D23-A378-AABFD7E37061Q33844617-695B35F0-FC6A-43BC-A889-58B143C09654Q35096279-9136F862-EE30-479B-A1A2-9E23E8A71411Q35110244-A0FBACDF-617D-4CD0-8322-1F9AE5F02127Q35841917-86797911-453A-44C5-B431-EEB9233F367DQ36159665-D3196684-E251-4F6F-97BC-3823FE70CF62Q36510045-D10DAAD2-7FC3-4478-9A5C-33050FA22538Q36571988-15392898-0FB4-4538-A7CD-E7EFBBDDA24AQ36634744-59C59211-90C2-4C74-AE5F-F037D299A7A7Q36854114-72375A25-3C53-4FCE-B768-FFFF29675AC2Q37253101-4B98F527-770A-4DEF-80BB-2ACE9C040DF6Q37354043-A8C9CE07-8315-47D0-93E0-1519A1769FECQ37443240-9C9AC37C-FBC5-4E15-8E6B-628E9E3CA975Q37825589-5BBE3D12-9BEE-44AF-96D9-B129AAF5F381Q37885396-342A9B93-E021-4EC7-8285-57F90178F143Q38131445-15738034-4789-4EF6-AEB1-BD563DB4055EQ38647611-6A465197-1E94-4EF1-8D72-7B7EB3E878EFQ38714956-7D5FE606-E893-49C5-9551-040B07C60229Q38898201-458F36EF-C1D4-438E-8038-1D71427A2CA7Q39392448-2E36A30D-66EC-45DF-8CC2-68FF80BCF964Q39794883-02A01157-94E9-4815-9542-2DDE0F8E5821Q41820498-5FCA07AF-0F25-4DC9-A536-D2CECDEFE989Q46782936-EF70BF40-4C88-4175-8F6B-1F1600FE7B11Q49875701-9BD75E64-B8A7-4F73-9F33-99EA3E583017Q51550616-222B7AB0-34B1-492B-A12B-EDF8E29FA322
P2860
Differences in airway remodeling between asthma and chronic obstructive pulmonary disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Differences in airway remodeli ...... obstructive pulmonary disease.
@ast
Differences in airway remodeli ...... obstructive pulmonary disease.
@en
type
label
Differences in airway remodeli ...... obstructive pulmonary disease.
@ast
Differences in airway remodeli ...... obstructive pulmonary disease.
@en
prefLabel
Differences in airway remodeli ...... obstructive pulmonary disease.
@ast
Differences in airway remodeli ...... obstructive pulmonary disease.
@en
P356
P1476
Differences in airway remodeli ...... obstructive pulmonary disease.
@en
P2093
Atsushi Nagai
Kazutetsu Aoshiba
P2888
P356
10.1385/CRIAI:27:1:035
P577
2004-08-01T00:00:00Z
P6179
1002682573